Research Begin Period Cash Flow vs Sale Purchase Of Stock Analysis

REFR Stock

USD 1.95 0.01 0.52%

Research Frontiers financial indicator trend analysis is much more than just breaking down Research Frontiers prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Research Frontiers is a good investment. Please check the relationship between Research Frontiers Begin Period Cash Flow and its Sale Purchase Of Stock accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Research Frontiers Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

Begin Period Cash Flow vs Sale Purchase Of Stock

Begin Period Cash Flow vs Sale Purchase Of Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Research Frontiers Begin Period Cash Flow account and Sale Purchase Of Stock. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Research Frontiers' Begin Period Cash Flow and Sale Purchase Of Stock is -0.06. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Sale Purchase Of Stock in the same time period over historical financial statements of Research Frontiers Incorporated, assuming nothing else is changed. The correlation between historical values of Research Frontiers' Begin Period Cash Flow and Sale Purchase Of Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Research Frontiers Incorporated are associated (or correlated) with its Sale Purchase Of Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Sale Purchase Of Stock has no effect on the direction of Begin Period Cash Flow i.e., Research Frontiers' Begin Period Cash Flow and Sale Purchase Of Stock go up and down completely randomly.

Correlation Coefficient

-0.06

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Sale Purchase Of Stock

Most indicators from Research Frontiers' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Research Frontiers current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Research Frontiers Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

At this time, Research Frontiers' Selling General Administrative is relatively stable compared to the past year. As of 11/29/2024, Enterprise Value is likely to grow to about 57.4 M, while Issuance Of Capital Stock is likely to drop 0.00.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	3.1M	3.2M	583.3K	554.1K
Cost Of Revenue	2.5M	175.2K	2.4M	2.6M

Total Operating Expenses Cost Of Revenue

Research Frontiers fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Total	Other Current Assets	Accounts Payable	Net Receivables	Short Term Investments	Other Assets	Common Stock Total Equity	Common Stock	Property Plant Equipment	Current Deferred Revenue
Total Assets		-0.01	-0.21	1.0	0.03	-0.88	-0.04	0.89	0.31	-0.36	0.95	-0.02	0.16	-0.24	-0.27	0.99	-0.2	-0.18	-0.28	-0.24	0.66	-0.07	-0.12	-0.07	-0.02	-0.17
Other Current Liab	-0.01		0.78	-0.01	0.12	-0.16	0.65	0.03	0.24	0.09	0.04	-0.59	-0.46	-0.05	-0.65	-0.05	-0.28	0.53	0.56	0.63	0.06	-0.31	-0.64	-0.65	0.66	-0.02
Total Current Liabilities	-0.21	0.78		-0.23	0.22	-0.01	0.54	-0.05	0.38	0.41	-0.23	-0.48	-0.5	0.32	-0.23	-0.28	-0.01	0.52	0.65	0.67	-0.33	-0.31	-0.42	-0.43	0.56	-0.02
Total Stockholder Equity	1.0	-0.01	-0.23		-0.01	-0.87	-0.03	0.87	0.28	-0.36	0.95	-0.04	0.15	-0.31	-0.27	0.99	-0.27	-0.17	-0.28	-0.23	0.69	-0.1	-0.14	-0.1	-0.02	-0.2
Property Plant And Equipment Net	0.03	0.12	0.22	-0.01		-0.05	-0.43	0.11	0.7	-0.22	-0.08	0.48	0.47	0.56	0.1	-0.07	0.49	-0.33	-0.29	-0.23	-0.39	0.3	0.38	0.45	0.55	-0.21
Net Debt	-0.88	-0.16	-0.01	-0.87	-0.05		-0.11	-0.98	-0.33	0.3	-0.9	0.07	-0.09	0.11	0.45	-0.87	0.1	0.11	0.08	0.08	-0.43	0.0	0.15	0.11	0.09	0.18
Retained Earnings	-0.04	0.65	0.54	-0.03	-0.43	-0.11		0.03	-0.21	0.42	0.09	-0.88	-0.89	-0.18	-0.53	-0.01	-0.31	0.9	0.9	0.89	0.26	-0.21	-0.81	-0.85	0.06	0.26
Cash	0.89	0.03	-0.05	0.87	0.11	-0.98	0.03		0.35	-0.23	0.87	-0.03	0.1	-0.01	-0.34	0.87	0.0	-0.17	-0.12	-0.13	0.36	0.07	-0.09	-0.03	-0.16	-0.2
Non Current Assets Total	0.31	0.24	0.38	0.28	0.7	-0.33	-0.21	0.35		-0.14	0.15	0.22	0.26	0.27	0.0	0.17	0.12	-0.21	-0.14	-0.09	-0.22	0.11	0.13	0.18	0.56	-0.3
Non Currrent Assets Other	-0.36	0.09	0.41	-0.36	-0.22	0.3	0.42	-0.23	-0.14		-0.46	-0.51	-0.72	0.09	0.37	-0.36	-0.09	0.55	0.66	0.64	-0.38	-0.06	-0.29	-0.31	-0.13	-0.1
Cash And Short Term Investments	0.95	0.04	-0.23	0.95	-0.08	-0.9	0.09	0.87	0.15	-0.46		-0.03	0.14	-0.25	-0.41	0.96	-0.16	-0.08	-0.18	-0.15	0.76	-0.07	-0.13	-0.1	-0.09	-0.02
Common Stock Shares Outstanding	-0.02	-0.59	-0.48	-0.04	0.48	0.07	-0.88	-0.03	0.22	-0.51	-0.03		0.94	0.3	0.47	-0.05	0.48	-0.75	-0.74	-0.72	-0.22	0.3	0.95	0.97	-0.05	-0.09
Other Stockholder Equity	0.16	-0.46	-0.5	0.15	0.47	-0.09	-0.89	0.1	0.26	-0.72	0.14	0.94		0.14	0.26	0.13	0.31	-0.84	-0.87	-0.83	-0.06	0.19	0.81	0.84	0.05	-0.16
Total Liab	-0.24	-0.05	0.32	-0.31	0.56	0.11	-0.18	-0.01	0.27	0.09	-0.25	0.3	0.14		0.12	-0.29	0.93	-0.1	0.11	0.01	-0.5	0.32	0.35	0.42	0.0	0.38
Property Plant And Equipment Gross	-0.27	-0.65	-0.23	-0.27	0.1	0.45	-0.53	-0.34	0.0	0.37	-0.41	0.47	0.26	0.12		-0.28	0.14	-0.25	-0.26	-0.24	-0.32	-0.02	0.62	0.6	-0.13	-0.24
Total Current Assets	0.99	-0.05	-0.28	0.99	-0.07	-0.87	-0.01	0.87	0.17	-0.36	0.96	-0.05	0.13	-0.29	-0.28		-0.22	-0.16	-0.27	-0.23	0.72	-0.09	-0.14	-0.1	-0.11	-0.13
Non Current Liabilities Total	-0.2	-0.28	-0.01	-0.27	0.49	0.1	-0.31	0.0	0.12	-0.09	-0.16	0.48	0.31	0.93	0.14	-0.22		-0.21	-0.05	-0.16	-0.36	0.45	0.51	0.58	-0.2	0.47
Other Current Assets	-0.18	0.53	0.52	-0.17	-0.33	0.11	0.9	-0.17	-0.21	0.55	-0.08	-0.75	-0.84	-0.1	-0.25	-0.16	-0.21		0.91	0.93	0.21	-0.12	-0.62	-0.67	0.12	0.28
Accounts Payable	-0.28	0.56	0.65	-0.28	-0.29	0.08	0.9	-0.12	-0.14	0.66	-0.18	-0.74	-0.87	0.11	-0.26	-0.27	-0.05	0.91		0.97	-0.03	-0.13	-0.58	-0.63	0.05	0.27
Net Receivables	-0.24	0.63	0.67	-0.23	-0.23	0.08	0.89	-0.13	-0.09	0.64	-0.15	-0.72	-0.83	0.01	-0.24	-0.23	-0.16	0.93	0.97		0.02	-0.14	-0.56	-0.62	0.19	0.2
Short Term Investments	0.66	0.06	-0.33	0.69	-0.39	-0.43	0.26	0.36	-0.22	-0.38	0.76	-0.22	-0.06	-0.5	-0.32	0.72	-0.36	0.21	-0.03	0.02		-0.26	-0.29	-0.3	-0.01	0.22
Other Assets	-0.07	-0.31	-0.31	-0.1	0.3	0.0	-0.21	0.07	0.11	-0.06	-0.07	0.3	0.19	0.32	-0.02	-0.09	0.45	-0.12	-0.13	-0.14	-0.26		0.28	0.33	-0.21	0.38
Common Stock Total Equity	-0.12	-0.64	-0.42	-0.14	0.38	0.15	-0.81	-0.09	0.13	-0.29	-0.13	0.95	0.81	0.35	0.62	-0.14	0.51	-0.62	-0.58	-0.56	-0.29	0.28		0.98	-0.15	-0.06
Common Stock	-0.07	-0.65	-0.43	-0.1	0.45	0.11	-0.85	-0.03	0.18	-0.31	-0.1	0.97	0.84	0.42	0.6	-0.1	0.58	-0.67	-0.63	-0.62	-0.3	0.33	0.98		-0.15	-0.06
Property Plant Equipment	-0.02	0.66	0.56	-0.02	0.55	0.09	0.06	-0.16	0.56	-0.13	-0.09	-0.05	0.05	0.0	-0.13	-0.11	-0.2	0.12	0.05	0.19	-0.01	-0.21	-0.15	-0.15		-0.15
Current Deferred Revenue	-0.17	-0.02	-0.02	-0.2	-0.21	0.18	0.26	-0.2	-0.3	-0.1	-0.02	-0.09	-0.16	0.38	-0.24	-0.13	0.47	0.28	0.27	0.2	0.22	0.38	-0.06	-0.06	-0.15

Click cells to compare fundamentals

Research Frontiers Account Relationship Matchups

Research Frontiers fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	8.3M	6.2M	4.5M	5.4M	3.9M	7.2M
Other Current Liab	46.7K	(140.1K)	(132.7K)	(162.0K)	(198.2K)	(188.3K)
Total Current Liabilities	387.4K	226.1K	297.9K	301.9K	277.4K	300.0K
Total Stockholder Equity	7.1M	5.3M	3.8M	4.8M	3.5M	6.8M
Property Plant And Equipment Net	915.7K	738.2K	562.8K	388.9K	218.3K	294.7K
Net Debt	(5.6M)	(4.0M)	376.3K	(3.8M)	(2.2M)	(2.3M)
Retained Earnings	(115.5M)	(117.8M)	(119.7M)	(122.4M)	(124.3M)	(118.1M)
Cash	6.6M	4.8M	270.0K	4.2M	2.5M	3.8M
Non Current Assets Total	949.3K	771.8K	596.3K	445.0K	274.4K	437.8K
Cash And Short Term Investments	6.6M	4.8M	3.0M	4.2M	2.5M	2.4M
Common Stock Shares Outstanding	30.0M	31.5M	31.6M	32.1M	33.5M	17.6M
Liabilities And Stockholders Equity	8.3M	6.2M	4.5M	5.4M	3.9M	7.2M
Other Stockholder Equity	122.6M	123.2M	123.5M	127.2M	127.8M	72.8M
Total Liab	1.2M	872.3K	762.1K	569.6K	332.8K	497.2K
Property Plant And Equipment Gross	915.7K	738.2K	3.3M	3.1M	3.0M	3.1M
Total Current Assets	7.3M	5.4M	3.9M	4.9M	3.6M	6.8M
Non Current Liabilities Total	812.6K	646.2K	464.1K	267.7K	55.4K	52.6K
Other Current Assets	58.8K	113.0K	185.9K	101.0K	96.8K	91.9K
Accounts Payable	169.8K	33.4K	66.5K	71.1K	50.9K	48.3K
Net Receivables	656.1K	598.3K	831.6K	589.6K	1.0M	527.4K
Common Stock Total Equity	2.8K	3.1K	3.2K	3.3K	3.8K	2.2K
Common Stock	3.1K	3.2K	3.2K	3.3K	3.4K	2.3K
Property Plant Equipment	141.7K	121.8K	562.8K	65.4K	75.2K	71.4K
Current Deferred Revenue	50.6K	7.7K	49.0K	1.0	1.15	1.09
Net Tangible Assets	7.1M	5.3M	3.8M	4.8M	4.3M	5.5M
Retained Earnings Total Equity	(111.7M)	(115.5M)	(117.8M)	(122.4M)	(110.1M)	(115.6M)
Capital Surpluse	114.8M	122.6M	123.2M	127.2M	146.2M	122.8M
Net Invested Capital	7.1M	5.3M	3.8M	4.8M	3.5M	4.7M
Net Working Capital	6.9M	5.2M	3.7M	4.6M	3.3M	4.6M
Capital Stock	3.1K	3.2K	3.2K	3.3K	3.4K	3.5K

Pair Trading with Research Frontiers

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Research Frontiers position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Research Frontiers will appreciate offsetting losses from the drop in the long position's value.

Moving against Research Stock

0.52	KVHI	KVH Industries	Pair Corr
0.38	KULR	KULR Technology Group	Pair Corr
0.34	IONQ	IONQ Inc	Pair Corr
0.32	UKOMW	Ucommune International	Pair Corr
0.31	IDCC	InterDigital	Pair Corr

The ability to find closely correlated positions to Research Frontiers could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Research Frontiers when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Research Frontiers - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Research Frontiers Incorporated to buy it.

The correlation of Research Frontiers is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Research Frontiers moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Research Frontiers moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Research Frontiers can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Research Stock Analysis

When running Research Frontiers' price analysis, check to measure Research Frontiers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Research Frontiers is operating at the current time. Most of Research Frontiers' value examination focuses on studying past and present price action to predict the probability of Research Frontiers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Research Frontiers' price. Additionally, you may evaluate how the addition of Research Frontiers to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC